Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Mar 21:13:11.
doi: 10.1186/1758-2652-13-11.

High survival and treatment success sustained after two and three years of first-line ART for children in Cambodia

Petros Isaakidis  1 , Marie-Eve Raguenaud, Vantha Te, Chhraing S Tray, Kazumi Akao, Varun Kumar, Sopheak Ngin, Eric Nerrienet, Rony Zachariah
Affiliations

High survival and treatment success sustained after two and three years of first-line ART for children in Cambodia

Petros Isaakidis et al. J Int AIDS Soc. .

Abstract

Background: Long-term outcomes of antiretroviral therapy (ART) in children remain poorly documented in resource-limited settings. The objective of this study was to assess two-and three-year survival, CD4 evolution and virological response among children on ART in a programmatic setting in Cambodia.

Methods: Children treated with first-line ART for at least 24 months were assessed with viral load testing and genotyping. We used Kaplan-Meier analysis for survival and Cox regression to identify risk factors associated with treatment failure.

Results: Of 1168 registered HIV-positive children, 670 (57%) started ART between January 2003 and December 2007. Survival probability was 0.93 (95% CI: 0.91-0.95) and 0.91 (95% CI: 0.88-0.93) at 24 and 36 months after ART initiation, respectively. Median CD4 gain for children aged over five years was 704 cells/mm3 at 24 months and 737 at 36 months. Median CD4 percentage gain for children under five years old was 15.2% at 24 months and 15% at 36 months. One hundred and thirty children completed at least 24 months of ART, and 138 completed 36 months: 128 out of 268 (48%) were female. Median age at ART initiation was six years.Overall, 22 children had viral loads of >1000 copies/ml (success ratio = 86% on intention-to-treat-analysis) and 21 of 21 presented mutations conferring resistance mostly to lamivudine and non-nucleoside reverse transcriptase inhibitors. Risk factors for failure after 24 and 36 months were CD4 counts below the threshold for severe immunosupression at those months respectively. Only two out of 22 children with viral loads of >1000 copies/ml met the World Health Organization immunological criteria for failure (sensitivity = 0.1).

Conclusions: Good survival, immunological restoration and viral suppression can be sustained after two to three years of ART among children in resource-constrained settings. Increased access to routine virological measurements is needed for timely diagnosis of treatment failure.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Survival of children who started ART, 2002-2008, Takeo and Siem Reap, Cambodia
Figure 2
Figure 2
Flow chart of HIV-positive children on ART
Figure 3
Figure 3
Evolution of CD4 count/mm3 and CD4% over time in pediatric cohort on first-line ART for at least 24 months.
Figure 4
Figure 4
Most frequently found mutations in patients on ART >24 months.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Sutcliffe CG, van Kijk JH, Bolton C, Persaud D, Moss WJ. Effectiveness of antiretroviral therapy among HIV-infected children in sub-Saharan Africa. Lancet Infect Dis. 2008;13:477–89. doi: 10.1016/S1473-3099(08)70180-4. - DOI - PubMed
    1. Ciaranello AL, Chang Y, Margulis AV, Bernstein A, Bassett IV, Losina E, Walensky RP. Effectiveness of pediatric antiretroviral therapy in resource-limited settings: a systematic review and meta-analysis. Clin Infect Dis. 2009;13(12):1915–27. doi: 10.1086/648079. - DOI - PMC - PubMed
    1. O'Brien DP, Sauvageot D, Zachariah R, Humblet P. In resource-limited settings good early outcomes can be achieved in children using adult fixed-dose combination antiretroviral therapy. AIDS. 2006;13:1955–60. doi: 10.1097/01.aids.0000247117.66585.ce. - DOI - PubMed
    1. Janssens B, Raleigh B, Soeung S, Akao K, Te V, Gupta J, Vun MC, Ford N, Nouhin J, Nerrienet E. Effectiveness of highly active antiretroviral therapy in HIV-positive children: evaluation at 12 months in a routine program in Cambodia. Pediatrics. 2007;13:1134–1134. doi: 10.1542/peds.2006-3503. - DOI - PubMed
    1. Raguenaud ME, Isaakidis P, Zachariah R, Te V, Soeung S, Akao K, Kumar V. Excellent outcomes among HIV+ children on ART, but unacceptably high pre-ART mortality and losses to follow-up: a cohort study from Cambodia. BMC Pediatr. 2009;13:54. doi: 10.1186/1471-2431-9-54. - DOI - PMC - PubMed

Publication types

Substances